Skip to content
监管与产业动态· FierceBiotech·· 1 day agoPickScore53

Labcorp pays $722M in upfront cash deal for BioReference Health assets - Fierce Biotech

In brief

Labcorp is acquiring BioReference Health assets in a deal with $722 million in upfront cash.

Why it matters

Industry deal with a specific upfront cash figure of interest to readers.

Source: 监管与产业动态

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org